Gefitinib is indicated as monotherapy for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK.
For this indication, competent medicine agencies globally authorize below treatments:
Oral
250 - 250 mg
From 250 To 250 mg once every day
The recommended posology of gefitinib is one 250 mg once a day. If a dose is missed, it should be taken as soon as the patient remembers. If it is less than 12 hours to the next dose, the patient should not take the missed dose. Patients should not take a double dose (two doses at the same time) to make up for a forgotten dose.
It may be taken orally with or without food, at about the same time each day.